Matches in Nanopublications for { ?s ?p "DDI between Amprenavir and Tacrolimus - The protease inhibitor, Amprenavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Amprenavir therapy is initiated, discontinued or altered. [drugbank_resource:DB00701_DB00864]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00701_DB00864 label "DDI between Amprenavir and Tacrolimus - The protease inhibitor, Amprenavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Amprenavir therapy is initiated, discontinued or altered. [drugbank_resource:DB00701_DB00864]" assertion.